Genocea Biosciences (GNCA)

Genocea Biosciences (GNCA) Financial Statements


Genocea Biosciences Financial Overview

Genocea Biosciences's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Genocea Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement-
Total Revenue$ 270.00K$ 0.00$ 1.64M$ 0.00$ 0.00
Gross Profit-----
EBIT$ -15.75M$ -13.01M$ -3.33M$ -4.03M$ -11.70M
EBITDA$ -15.35M$ -12.60M$ -2.94M$ -3.66M$ -11.32M
Net Income Common Stockholders$ -15.98M$ -13.28M$ -3.62M$ -4.31M$ -11.98M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 20.14M$ 37.15M$ 48.91M$ 60.40M$ 66.03M
Total Assets$ 38.79M$ 55.97M$ 64.92M$ 77.38M$ 83.94M
Total Debt$ 15.48M$ 17.18M$ 18.85M$ 19.25M$ 19.64M
Net Debt$ -4.65M$ -19.96M$ -30.06M$ -41.15M$ -46.39M
Total Liabilities$ 26.40M$ 28.89M$ 27.09M$ 73.33M$ 82.18M
Stockholders Equity$ 12.38M$ 27.07M$ 37.83M$ 4.05M$ 1.76M
Cash Flow-
Free Cash Flow$ -16.17M$ -12.04M$ -11.89M$ -11.23M$ -13.50M
Operating Cash Flow$ -15.21M$ -11.11M$ -11.36M$ -10.51M$ -12.39M
Investing Cash Flow$ -939.00K$ -920.00K$ -530.00K$ -714.00K$ -1.04M
Financing Cash Flow$ -863.00K$ 265.00K$ 399.00K$ 5.59M$ -297.00K
Currency in USD

Genocea Biosciences Earnings and Revenue History

Genocea Biosciences Debt to Assets

Genocea Biosciences Cash Flow

Genocea Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis